HUGE news yesterday, but the stock barely moved because final dilutive shares are still being sold into market. Very big contracts expected in coming weeks, maybe this week even. Their drug was approved in Nigeria in 2016 and just yesterday announced marketing approval from Nigeria.
About $10m in debt. Expects to reach profitability in 2017, and capture "20% of billion dollar Nigerian HIV market within 12-18 months" according to yesterday's publishing.
Anything I'm missing here? I've done extreme DD. Seems like a no brainer. What do you guys think?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.